Article

Proteomics profiling reveals biomarkers for predicting diagnosis, disease activity and long-term disability outcome in multiple sclerosis

2023-03-16

Abstract excerpt

<title>Abstract</title> <p>To personalize multiple sclerosis (MS) treatment strategies, sensitive and reliable protein biomarkers are needed to predict disease trajectory. We used protein profiling based on the highly sensitive proximity extension assay combined with next generation sequencing (Olink Explore) to measure 1463 proteins in cerebrospinal fluid (CSF) and plasma from 143 people with early-stage MS and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9867334f-afa2-535d-8453-d0ee30b61f04
DOI: 10.21203/rs.3.rs-2678518/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Proteomics profiling reveals biomarkers for predicting diagnosis, disease activity and long-term disability outcome in multiple sclerosisDOI 10.21203/rs.3.rs-2678518/v1Read

Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosisSemantic proximity Read

Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosisSemantic proximity Read

Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisSemantic proximity Read

Plasma proteome in multiple sclerosis disease progressionSemantic proximity Read

Molecular markers in the CSF proteome differentiate neuroinflammatory diseasesSemantic proximity Read

Proteomics Reveals Age as Major Modifier of Inflammatory CSF Signatures in Multiple SclerosisSemantic proximity Read

Genetic-Proteomic Integration Identifies Predictive Plasma Proteins for Multiple Sclerosis.Semantic proximity Read

Neurofilament light chain: a biomarker at the crossroads of clarity and confusion for gene-directed therapiesSemantic proximity Read

Biomarkers of Therapeutic Response in Multiple Sclerosis: Current StatusSemantic proximity Read

Novel plasma and brain proteins that are implicated in multiple sclerosisSemantic proximity Read

Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosisSemantic proximity Read

Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applicationsSemantic proximity Read